Cash Flow Statement
Growth Metrics

Orthofix Medical (OFIX) Asset Writedowns and Impairment (2016 - 2019)

Orthofix Medical has reported Asset Writedowns and Impairment over the past 9 years, most recently at $1.0 million for Q4 2019.

  • For the quarter ending Q4 2019, Asset Writedowns and Impairment rose 3778.57% year-over-year to $1.0 million, compared with a TTM value of $1.9 million through Dec 2019, up 415.69%, and an annual FY2022 reading of $2.1 million, up 371.85% over the prior year.
  • Asset Writedowns and Impairment came in at $1.0 million for Q4 2019, up from $223000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $4.8 million in Q3 2017 to a low of -$3.9 million in Q4 2017.
  • Median Asset Writedowns and Impairment over the past 4 years was $162500.0 (2016), compared with a mean of $253000.0.
  • The largest YoY upside for Asset Writedowns and Impairment was 4571.57% in 2017 against a maximum downside of 6903.45% in 2017.
  • Over 4 years, Asset Writedowns and Impairment stood at $58000.0 in 2016, then plummeted by 6903.45% to -$3.9 million in 2017, then skyrocketed by 99.29% to -$28000.0 in 2018, then soared by 3778.57% to $1.0 million in 2019.
  • Per Business Quant, the three most recent readings for OFIX's Asset Writedowns and Impairment are $1.0 million (Q4 2019), $223000.0 (Q3 2019), and $592000.0 (Q2 2019).